Scrip
Biogen Idec reports sixth case of PML with Tysabri in 12 months
21 April 2009
Katie McQue
A sixth case of progressive multifocal leucoencephalopathy (PML) in the past 12 months has been reported in a patient taking
Biogen Idec's multiple sclerosis drug Tysabri (natalizumab).
The case was confirmed on April 15th – a day before the Massachusetts-based firm's first-quarter earnings conference...
Please Login to read the full article.
21 April 2009
Katie McQue
The case was confirmed on April 15th – a day before the Massachusetts-based firm's first-quarter earnings conference...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
FEATURES
- Debate for a new R&D model must start now
- Roche's Asian partnering head looks to tap regional innovation
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
